Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.56
-0.1349-0.55%
Post-market: 24.55-0.0094-0.04%16:10 EDT
Volume:2K
Turnover:51.59K
Market Cap:5.65M
PE:- -
High:24.72
Open:24.72
Low:24.47
Close:24.69
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:7.12
T/O Rate:0.91%
Dividend:0.41
Dividend Rate:1.68%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Viking Therapeutics Phase 1 data ‘highly encouraging,’ says H.C. Wainwright

TIPRANKS
·
Sep 22

Viking Therapeutics obesity data ‘very positive,’ says Morgan Stanley

TIPRANKS
·
Sep 22

Sandisk, GameStop, Viking Therapeutics, Vicor, on Holding, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 22

Viking Therapeutics obesity data ‘best-case scenario,’ says Truist

TIPRANKS
·
Sep 22

Under the Rader: Viking Stock Gains on Weight-Loss Study

Dow Jones
·
Sep 22

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Viking Therapeutics rises 32.5%

TIPRANKS
·
Sep 22

Why Is Viking Therapeutics Stock (VKTX) Up 32% Today?

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Stock News
·
Sep 22

Sector Update: Healthcare

MT Newswires Live
·
Sep 22

Novo Nordisk (NVO) Receives a Hold from Jefferies

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump

MT Newswires Live
·
Sep 22

Hope Fuels Markets but Reality Could Bite

Dow Jones
·
Sep 22

Viking Therapeutics Reports Strong Obesity Drug Maintenance Data

TIPRANKS
·
Sep 22

Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study

THOMSON REUTERS
·
Sep 22

Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study

Reuters
·
Sep 22